Drug Shortage Report for TOBRAMYCIN FOR INJECTION
| Report ID | 229350 |
| Drug Identification Number | 00533688 |
| Brand name | TOBRAMYCIN FOR INJECTION |
| Common or Proper name | TOBRAMYCIN FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 1.2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 50mL |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2024-06-01 |
| Estimated end date | 2024-07-05 |
| Actual end date | 2024-07-02 |
| Shortage status | Resolved |
| Updated date | 2024-07-04 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Tobramycin for Injection 1.2 g powder PBP Vial 50 mL effective June 1, 2024 until July 5, 2024. During this time, our Tobramycin Injection 40 mg/mL MD Vial 30 mL is available for substitution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-07-04 | French | Compare |
| v4 | 2024-07-04 | English | Compare |
| v3 | 2024-06-02 | English | Compare |
| v2 | 2024-05-31 | French | Compare |
| v1 | 2024-05-31 | English | Compare |
Showing 1 to 5 of 5